202.52MMarket Cap-6426P/E (TTM)
8.420High8.173Low9.11KVolume8.173Open8.485Pre Close75.67KTurnover0.04%Turnover RatioLossP/E (Static)24.43MShares15.49052wk High4.42P/B184.14MFloat Cap7.11052wk Low--Dividend TTM22.21MShs Float28.970Historical High--Div YieldTTM2.91%Amplitude3.100Historical Low8.304Avg Price1Lot Size
Profound Medical Stock Forum
NEWS
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
Profound Medical Corp.'s TULSA procedure is gaining recognition as a mainstream treatment for prostate diseases, with 25 scientific research presentations this year alone. The clinical evidence showcases TULSA's efficacy in treating a diverse range of patients with localized prostate c...
No comment yet